EFFECTS OF INTRATHECAL SUBSTANCE-P AND A SUBSTANCE-P ANTAGONIST ON A REFLEX TO NOXIOUS HEAT ARE INDEPENDENT OF CHANGES IN TAIL SKIN TEMPERATURE

被引:1
|
作者
EIDE, PK
机构
[1] Department of Physiology, University of Bergen, N-5009 Bergen
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 1990年 / 140卷 / 04期
关键词
mouse; Spantide; substance P; tail skin temperature; tail-flick reflex;
D O I
10.1111/j.1748-1716.1990.tb09031.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Substance P or the substance P receptor antagonist (D-Arg1,D-Trp7,9,Leu11)-substance P (Spantide) was injected into the lumbar subarachnoid space in mice, and the ability to change the tail-flick reflex and the tail skin temperature was investigated. Tail-flick latency (the time needed to evoke the tail-flick reflex by noxious radiant heat) was reduced for 1-4 min after intrathecal administration of substance P (5 μg), but the tail skin temperature was not significantly changed. Nor was the tail skin temperature significantly changed after intrathecal injection of Spantide (5 μg), but this compound significantly increased tail-flick latencies 5-30 min after injection. Analysis of co-variance showed that the effects of substance P or Spantide on tail-flick latency were significant, whereas the influence of tail skin temperature on tail-flick latency was non-significant. Thus, intrathecal substance P induces a short-lasting increase in nociceptive sensitivity, and intrathecal Spantide produces an antinociceptive effect of longer duration. The results seem not to be the result of changes in tail skin temperature.
引用
收藏
页码:539 / 543
页数:5
相关论文
共 50 条
  • [31] INTRATHECAL SUBSTANCE-P DEPRESSES THE TAIL-FLICK RESPONSE - ANTAGONISM BY NALOXONE
    DOI, T
    JURNA, I
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 317 (02) : 135 - 139
  • [32] INHIBITION OF ANTIDROMIC AND SUBSTANCE-P-INDUCED VASODILATATION BY A SUBSTANCE-P ANTAGONIST
    ROSELL, S
    OLGART, L
    GAZELIUS, B
    PANOPOULOS, P
    FOLKERS, K
    HORIG, J
    ACTA PHYSIOLOGICA SCANDINAVICA, 1981, 111 (03): : 381 - 382
  • [33] THE EFFECT OF SUBSTANCE-P AND SUBSTANCE-P FRAGMENTS ON THE THRESHOLD OF PAIN IN THE MOUSE
    GORNE, RC
    MORGENSTERN, E
    OEHME, P
    BIENERT, M
    NEUBERT, K
    PHARMAZIE, 1982, 37 (04): : 299 - 300
  • [34] PROPERTIES OF SUBSTANCE-P AGGREGATES APPLICATION TO THE SYNTHESIS AND PURIFICATION OF SUBSTANCE-P
    POUJADE, C
    LAVIELLE, S
    CHASSAING, G
    MARQUET, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 114 (03) : 1109 - 1116
  • [35] SUBSTANCE-P AND SUBSTANCE-P RECEPTOR HISTOCHEMISTRY IN HUMAN NEURODEGENERATIVE DISEASES
    KOWALL, NW
    QUIGLEY, BJ
    LU, F
    KOSOFSKY, BE
    FERRANTE, RJ
    REGULATORY PEPTIDES, 1992, : S27 - S27
  • [36] COMPARISON OF CRUDE BOVINE SUBCORTICAL SUBSTANCE-P WITH SYNTHETIC SUBSTANCE-P
    IVEN, H
    ZETLER, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 276 (02) : 123 - 131
  • [37] SUBSTANCE-P AND SUBSTANCE-P RECEPTOR HISTOCHEMISTRY IN HUMAN NEURODEGENERATIVE DISEASES
    KOWALL, NW
    QUIGLEY, BJ
    KRAUSE, JE
    LU, F
    KOSOFSKY, BE
    FERRANTE, RJ
    REGULATORY PEPTIDES, 1993, 46 (1-2) : 174 - 185
  • [38] NEONATAL ADMINISTRATION OF SUBSTANCE-P INCREASES SENSITIVITY TO SUBSTANCE-P IN ADULTS
    HANDELMANN, GE
    SELSKY, JH
    NEUROENDOCRINOLOGY LETTERS, 1983, 5 (03) : 186 - 186
  • [39] SUBSTANCE-P MEDIATED INFLAMMATION - INHIBITORY ROLE OF SOMATOSTATIN AND SUBSTANCE-P ANTAGONIST - CP 96,345
    STANISZ, AM
    REGULATORY PEPTIDES, 1992, : S150 - S150
  • [40] EFFECT OF INTRATHECALLY ADMINISTERED SUBSTANCE-P ANTIBODY AND SUBSTANCE-P ANTAGONIST ON THE RESPONSES TO VENTROLATERAL MEDULLARY STIMULATION IN THE CAT
    VISSING, J
    IWAMOTO, GA
    RYBICKI, KJ
    FASEB JOURNAL, 1988, 2 (06): : A1728 - A1728